GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $206,000 | -22.6% | 4,735 | -22.4% | 0.03% | -12.1% |
| Q1 2022 | $266,000 | +1.9% | 6,103 | +3.2% | 0.03% | +3.1% |
| Q4 2021 | $261,000 | +13.0% | 5,913 | -2.2% | 0.03% | +3.2% |
| Q3 2021 | $231,000 | +14.4% | 6,045 | +6.7% | 0.03% | -24.4% |
| Q1 2021 | $202,000 | -1.5% | 5,664 | +0.4% | 0.04% | -14.6% |
| Q4 2020 | $205,000 | -8.1% | 5,640 | -4.7% | 0.05% | -21.3% |
| Q3 2020 | $223,000 | -19.5% | 5,921 | -13.3% | 0.06% | -26.5% |
| Q2 2020 | $277,000 | +8.6% | 6,829 | +1.5% | 0.08% | -9.8% |
| Q1 2020 | $255,000 | -21.1% | 6,725 | -2.0% | 0.09% | 0.0% |
| Q4 2019 | $323,000 | +6.6% | 6,861 | -2.9% | 0.09% | -2.1% |
| Q3 2019 | $303,000 | +7.1% | 7,068 | -0.5% | 0.09% | +16.0% |
| Q2 2019 | $283,000 | +26.9% | 7,104 | +34.0% | 0.08% | +22.7% |
| Q1 2019 | $223,000 | +11.5% | 5,300 | +10.9% | 0.07% | -31.2% |
| Q1 2017 | $200,000 | – | 4,779 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |